comparison of efficacy of topical phenytoin versus topical flucinolon in treatment of cutaneous lichen planus

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017081231028N3

Enrollment

Registered

2017-08-26

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cutaneous lichen planus. Other lichen planus

Interventions

Intervention 1: use of flucinolone cream twice daily for 8 weeks. Intervention 2: use of phenytoin cream twice daily for 8 weeks.

Treatment - Drugs

use of flucinolone cream twice daily for 8 weeks

use of phenytoin cream twice daily for 8 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: patients with cutaneous lichen planus visiting at Faghihi Hospital in 2013 - 2018 exclusion criteria: pregnant and lactating woman; use of systemic or topical steroid in last 1 month; sensitivity reaction to phenytoin or fluocinolone; patient has oral, genital, actinic, pigmentosus type of lichen planus; concomitant lichenplanopilaris.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Color of lesions. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Scale. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Thickness of lesion. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Pruritus. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: announcing the patient.	—

Measure

Time frame

Color of lesions. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Scale. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Thickness of lesion. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Pruritus. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: announcing the patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Hemmatian Boroujeni

Shiraz University Of Medical Sciences

n_hemmatian_b@yahoo.com+98 71 3231 9049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026